Patents by Inventor Karen-Marie Pedersen

Karen-Marie Pedersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SorCS1 for the treatment of obesity
    Patent number: 10172918
    Abstract: The present invention relates to SorCS1-like agents, including SorCS1, nucleic acid molecule encoding expression of SorCS1 and fragments thereof, as well as vectors containing said nucleic acid and to cells expressing SorCS1 and said fragments, for the treatment of obesity.
    Type: Grant
    Filed: June 9, 2016
    Date of Patent: January 8, 2019
    Assignee: Aarhus Universitet
    Inventors: Karen-Marie Pedersen, Anders Nykjaer, Mads Fuglsang Kjolby
  • SorCS1-like agent for use in the treatment of insulin resistance and diseases related thereto
    Patent number: 9931374
    Abstract: The present invention relates to Sor CS1-like agents, including Sor CS1, nucleic acid molecule encoding expression of Sor CS1 and fragments thereof, as well as vectors containing said nucleic acid and to cells expressing Sor CS1 and said fragments, for use in the treatment of insulin resistance.
    Type: Grant
    Filed: June 29, 2015
    Date of Patent: April 3, 2018
    Assignee: Aarhus Universitet
    Inventors: Karen-Marie Pedersen, Anders Nykjaer
  • SorCS1 for the Treatment of Obesity
    Publication number: 20170014476
    Abstract: The present invention relates to SorCS1-like agents, including SorCS1, nucleic acid molecule encoding expression of SorCS1 and fragments thereof, as well as vectors containing said nucleic acid and to cells expressing SorCS1 and said fragments, for the treatment of obesity.
    Type: Application
    Filed: June 9, 2016
    Publication date: January 19, 2017
    Inventors: Karen-Marie Pedersen, Anders Nykjaer, Mads Fuglsang Kjolby
  • SorCS1 for the treatment of obesity
    Patent number: 9387232
    Abstract: The present invention relates to SorCS1-like agents, including SorCS1, nucleic acid molecule encoding expression of SorCS1 and fragments thereof, as well as vectors containing said nucleic acid and to cells expressing SorCS1 and said fragments, for the treatment of obesity.
    Type: Grant
    Filed: December 15, 2011
    Date of Patent: July 12, 2016
    Assignee: Aarhus Universitet
    Inventors: Karen-Marie Pedersen, Anders Nykjaer, Mads Fuglsang Kjolby
  • SorCS1-Like Agent for Use in the Treatment of Insulin Resistance and Diseases Related Thereto
    Publication number: 20160015778
    Abstract: The present invention relates to Sor CS1-like agents, including Sor CS1, nucleic acid molecule encoding expression of Sor CS1 and fragments thereof, as well as vectors containing said nucleic acid and to cells expressing Sor CS1 and said fragments, for use in the treatment of insulin resistance.
    Type: Application
    Filed: June 29, 2015
    Publication date: January 21, 2016
    Inventors: Karen-Marie Pedersen, Anders Nykjaer
  • SorCS1-like agent for use in the treatment of insulin resistance and diseases related thereto
    Patent number: 9101117
    Abstract: The present invention relates to SorCS1-like agents, including SorCS1, nucleic acid molecule encoding expression of SorCS1 and fragments thereof, as well as vectors containing said nucleic acid and to cells expressing SorCS1 and said fragments, for use in the treatment of insulin resistance.
    Type: Grant
    Filed: June 10, 2010
    Date of Patent: August 11, 2015
    Assignee: Aarhus Universitet
    Inventors: Karen-Marie Pedersen, Anders Nykjaer
  • SorCS1 FOR USE IN THE TREATMENT OF OBESITY AND OVERWEIGHT
    Publication number: 20150166629
    Abstract: The present invention relates to SorCS1-like agents, including SorCS1, nucleic acid molecule encoding expression of SorCS1 and fragments thereof, as well as vectors containing said nucleic acid and to cells expressing SorCS1 and said fragments, for use in a method of reducing appetite, and/or for promoting weight loss, and/or for treating obesity, and/or for increasing metabolism, and/or for increasing thermogenesis, and/or for converting white fat into brown fat
    Type: Application
    Filed: April 17, 2013
    Publication date: June 18, 2015
    Inventors: Karen-Marie Pedersen, Anders Nykjær, Mads Fuglsang Kjølby
  • SORCS1 FOR THE TREATMENT OF OBESITY
    Publication number: 20120207721
    Abstract: The present invention relates to SorCS1-like agents, including SorCS1, nucleic acid molecule encoding expression of SorCS1 and fragments thereof, as well as vectors containing said nucleic acid and to cells expressing SorCS1 and said fragments, for the treatment of obesity.
    Type: Application
    Filed: December 15, 2011
    Publication date: August 16, 2012
    Applicant: AARHUS UNIVERSITET
    Inventors: Karen-Marie Pedersen, Anders Nykjaer, Mads Fuglsang Kjolby
  • SORCS1-LIKE AGENT FOR USE IN THE TREATMENT OF INSULIN RESISTANCE AND DISEASES RELATED THERETO
    Publication number: 20120156183
    Abstract: The present invention relates to SorCS1-like agents, including SorCS1, nucleic acid molecule encoding expression of SorCS1 and fragments thereof, as well as vectors containing said nucleic acid and to cells expressing SorCS1 and said fragments, for use in the treatment of insulin resistance.
    Type: Application
    Filed: June 10, 2010
    Publication date: June 21, 2012
    Applicant: AARHUS UNIVERSITET
    Inventors: Karen-Marie Pedersen, Anders Nykjaer